BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19244092)

  • 1. Pregnancy-induced rise in serum C-peptide concentrations in women with type 1 diabetes.
    Nielsen LR; Rehfeld JF; Pedersen-Bjergaard U; Damm P; Mathiesen ER
    Diabetes Care; 2009 Jun; 32(6):1052-7. PubMed ID: 19244092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma C-peptide concentration in women with Type 1 diabetes during early and late pregnancy.
    Murphy HR; Elleri D; Allen JM; Simmons D; Nodale M; Hovorka R
    Diabet Med; 2012 Oct; 29(10):e361-4. PubMed ID: 22804483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of eicosapentaenoic acid and docosahexaenoic acid supplementation on C-peptide preservation in pregnant women with type-1 diabetes: randomized placebo controlled clinical trial.
    Horvaticek M; Djelmis J; Ivanisevic M; Oreskovic S; Herman M
    Eur J Clin Nutr; 2017 Aug; 71(8):968-972. PubMed ID: 28378851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes.
    Maresh MJ; Holmes VA; Patterson CC; Young IS; Pearson DW; Walker JD; McCance DR;
    Diabetes Care; 2015 Jan; 38(1):34-42. PubMed ID: 25368104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycated albumin and glycated hemoglobin are influenced differently by endogenous insulin secretion in patients with type 2 diabetes.
    Koga M; Murai J; Saito H; Kasayama S
    Diabetes Care; 2010 Feb; 33(2):270-2. PubMed ID: 19846794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamic acid decarboxylase autoantibody-positivity post-partum is associated with impaired β-cell function in women with gestational diabetes mellitus.
    Lundberg TP; Højlund K; Snogdal LS; Jensen DM
    Diabet Med; 2015 Feb; 32(2):198-205. PubMed ID: 25345799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of an intrinsic relationship between endogenous C-peptide concentration and determinants of glycemic control in type 1 diabetes following islet transplantation.
    Brooks AM; Oram R; Home P; Steen N; Shaw JA
    Diabetes Care; 2015 Jan; 38(1):105-12. PubMed ID: 25422169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy.
    Kautzky-Willer A; Prager R; Waldhausl W; Pacini G; Thomaseth K; Wagner OF; Ulm M; Streli C; Ludvik B
    Diabetes Care; 1997 Nov; 20(11):1717-23. PubMed ID: 9353615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):30-6. PubMed ID: 2884229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.
    Ann Intern Med; 1998 Apr; 128(7):517-23. PubMed ID: 9518395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.
    Kautzky-Willer A; Thomaseth K; Ludvik B; Nowotny P; Rabensteiner D; Waldhäusl W; Pacini G; Prager R
    Diabetes; 1997 Apr; 46(4):607-14. PubMed ID: 9075800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol.
    Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR;
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin secretion measured by stimulated C-peptide in long-established Type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study.
    McGee P; Steffes M; Nowicki M; Bayless M; Gubitosi-Klug R; Cleary P; Lachin J; Palmer J;
    Diabet Med; 2014 Oct; 31(10):1264-8. PubMed ID: 24836354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal changes in pancreatic beta-cell function and metabolic clearance rate of insulin in pregnant women with normal and abnormal glucose tolerance.
    Catalano PM; Drago NM; Amini SB
    Diabetes Care; 1998 Mar; 21(3):403-8. PubMed ID: 9540023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real world management of pregestational diabetes not achieving glycemic control for many patients in the UK.
    Cea-Soriano L; García-Rodríguez LA; Brodovicz KG; Masso-Gonzalez E; Bartels DB; Hernández-Díaz S
    Pharmacoepidemiol Drug Saf; 2018 Aug; 27(8):940-948. PubMed ID: 29740916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obese Nondiabetic Pregnancies and High Maternal Glycated Hemoglobin at Delivery as an Indicator of Offspring and Maternal Postpartum Risks: The Prospective PEACHES Mother-Child Cohort.
    Ensenauer R; Brandlhuber L; Burgmann M; Sobotzki C; Zwafink C; Anzill S; Holdt L; Teupser D; Hasbargen U; Netz H; Roscher AA; von Kries R
    Clin Chem; 2015 Nov; 61(11):1381-90. PubMed ID: 26265704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin micro-secretion in Type 1 diabetes and related microRNA profiles.
    Januszewski AS; Cho YH; Joglekar MV; Farr RJ; Scott ES; Wong WKM; Carroll LM; Loh YW; Benitez-Aguirre PZ; Keech AC; O'Neal DN; Craig ME; Hardikar AA; Donaghue KC; Jenkins AJ
    Sci Rep; 2021 Jun; 11(1):11727. PubMed ID: 34083567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes.
    Picardi A; Visalli N; Lauria A; Suraci C; Buzzetti R; Merola MK; Manfrini S; Guglielmi C; Gentilucci UV; Pitocco D; Crinò A; Bizzarri C; Cappa M; Pozzilli P
    Horm Metab Res; 2006 Oct; 38(10):668-72. PubMed ID: 17075776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of insulin resistance on proinsulin secretion in pregnancy: hyperproinsulinemia is not a feature of gestational diabetes.
    Retnakaran R; Hanley AJ; Sermer M; Zinman B
    Diabetes Care; 2005 Nov; 28(11):2710-5. PubMed ID: 16249544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of insulin secretion and insulin resistance in the clinical course of newly diagnosed diabetes mellitus in children].
    Szadkowska A; Pietrzak I; Markuszewski L; Bodalski J
    Med Wieku Rozwoj; 2005; 9(2):223-34. PubMed ID: 16085963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.